SEARCH

SEARCH BY CITATION

References

  • 1
    Petersen RO. Prostate and seminal vesicles. In: Petersen RO (ed.). Urologic Pathology. J.B. Lippincott, Philadelphia, 1992; 575673.
  • 2
    Homma Y, Kawabe K, Tsukomato T et al. Estimate criteria for diagnosis and severity in benign prostatic hyperplasia. Int. J. Urol. 1996; 3: 2616.
  • 3
    Barry MJ, Beckley S, Boyle P et al. Importance of understanding the epidemiology and natural history of BPH. In: Cockett ATK, Aso Y, Chatelain C (eds). Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 26–7. World Health Organization, Geneva, 1992; 1321.
  • 4
    McConnel JD. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell's Urology. W.B. Saunders, Philadelphia, 1998; 142952.
  • 5
    Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hyperplasia in the community. Lancet 1991; 338: 46971.
  • 6
    Sagnier PP, Macfarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of epidemiological survey using a modified American Urological Association Symptom Index for benign prostatic hyperplasia in France. J. Urol. 1994; 151: 126670.
  • 7
    Hunter DJ, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old and older. J. Urol. 1996; 155: 196570.
  • 8
    Norman RW, Nickel JC, Fish D, Pickett SN. ‘Prostate-related symptoms’ in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br. J. Urol. 1994; 74: 54250.
  • 9
    Bosch JL, Hop WC, Kirkels WJ, Schroder FH. International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br. J. Urol. 1995; 75: 62230.
  • 10
    Tsukamoto T, Kumamoto Y, Masumori N et al. Prevalence of prostatism in Japanese men in a community-based study with comparison to similar American study. J. Urol. 1995; 154: 3915.
  • 11
    Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J. Urol. 1993; 150: 859.
  • 12
    Tan HY, Choo WC, Archibald C, Asuvaranathan K. A community based study of prostatic symptoms in Singapore. J. Urol. 1997; 157: 8903.
  • 13
    Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, Del Rosal-Samaniego JM, Rodero-Carcia P, Rodriguez-Vallejo JM. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J. Urol. 1998; 159: 87882.
  • 14
    Homma Y, Kawabe K, Tsukomato T et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score. Int. J. Urol. 1997; 3: 4406.
  • 15
    Lee E, Yoo KY, Kim Y et al. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur. Urol. 1998; 33: 1721.
  • 16
    Vela-Navarrete R, Alfaro V, Badiella LL, Fernandez-Hernando N. Age-stratified analysis of IPSS and QOL values in Spanish patients with symptoms potentially related to BPH. Eur. Urol. 2000; 38: 199207.